Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: An example of how S&L could responsibly move some of their shares.
Note second part of announcment in bold.
SAN FRANCISCO (CBS.MW) -- Oracle (ORCL
Oracle Corporation
Sponsored by:
ORCL ) revealed in a regulatory filing Wednesday that CEO Larry Ellison exercised 1 million stock options on Tuesday priced at about $1.69 a share and sold them the same day at prices ranging from $11.38 to $11.87 a share, netting nearly $10 million. The company announced last month that Ellison plans to sell 120 million of his roughly 1.4 billion Oracle shares over the next year, as part of a stock-selling plan. Oracle shares rose 13 cents to $11.83 in midsession trading.
New Message
Please
login
to post a reply